Characterization of a Linked Jumonji Domain of the KDM5/JARID1 Family of Histone H3 Lysine 4 Demethylases

Horton, John R.; Engstrom, Amanda; Zoeller, Elizabeth L.; Liu, Xu; Shanks, John R.; Zhang, Xing; Johns, Margaret A.; Vertino, Paula M.; Fu, Haian; Cheng, Xiaodong

doi:10.1074/jbc.M115.698449

Characterization of a Linked Jumonji Domain of the KDM5/JARID1 Family of Histone H3 Lysine 4 Demethylases

Journal Article · Tue Dec 08 00:00:00 EST 2015 · Journal of Biological Chemistry

DOI:https://doi.org/10.1074/jbc.M115.698449· OSTI ID:1237765

Horton, John R. ^[1]; Engstrom, Amanda ^[1]; Zoeller, Elizabeth L. ^[1]; Liu, Xu ^[1]; Shanks, John R. ^[1]; Zhang, Xing ^[1]; Johns, Margaret A. ^[1]; Vertino, Paula M. ^[1]; Fu, Haian ^[1]; Cheng, Xiaodong ^[1]

Emory Univ., Atlanta, GA (United States)

The KDM5/JARID1 family of Fe(II)- and α-ketoglutarate-dependent demethylases remove methyl groups from tri- and dimethylated lysine 4 of histone H3. Accumulating evidence from primary tumors and model systems supports a role for KDM5A (JARID1A/RBP2) and KDM5B (JARID1B/PLU1) as oncogenic drivers. The KDM5 family is unique among the Jumonji domain-containing histone demethylases in that there is an atypical insertion of a DNA-binding ARID domain and a histone-binding PHD domain into the Jumonji domain, which separates the catalytic domain into two fragments (JmjN and JmjC). Here we demonstrate that internal deletion of the ARID and PHD1 domains has a negligible effect on in vitro enzymatic kinetics of the KDM5 family of enzymes. We present a crystal structure of the linked JmjN-JmjC domain from KDM5A, which reveals that the linked domain fully reconstitutes the cofactor (metal ion and α-ketoglutarate) binding characteristics of other structurally characterized Jumonji domain demethylases. Docking studies with GSK-J1, a selective inhibitor of the KDM6/KDM5 subfamilies, identify critical residues for binding of the inhibitor to the reconstituted KDM5 Jumonji domain. Further, we found that GSK-J1 inhibited the demethylase activity of KDM5C with 8.5-fold increased potency compared with that of KDM5B at 1 mm α-ketoglutarate. In contrast, JIB-04 (a pan-inhibitor of the Jumonji demethylase superfamily) had the opposite effect and was ~8-fold more potent against KDM5B than against KDM5C. Interestingly, the relative selectivity of JIB-04 toward KDM5B over KDM5C in vitro translates to a ~10–50-fold greater growth-inhibitory activity against breast cancer cell lines. Here, these data define the minimal requirements for enzymatic activity of the KDM5 family to be the linked JmjN-JmjC domain coupled with the immediate C-terminal helical zinc-binding domain and provide structural characterization of the linked JmjN-JmjC domain for the KDM5 family, which should prove useful in the design of KDM5 demethylase inhibitors with improved potency and selectivity.

View Accepted Manuscript (DOE)

Research Organization:: Argonne National Laboratory (ANL), Argonne, IL (United States)

Sponsoring Organization:: NCI; National Inst. of Health (NIH)

OSTI ID:: 1237765

Journal Information:: Journal of Biological Chemistry, Journal Name: Journal of Biological Chemistry Journal Issue: 6 Vol. 291; ISSN 0021-9258

Publisher:: American Society for Biochemistry and Molecular BiologyCopyright Statement

Country of Publication:: United States

Language:: ENGLISH

References (76)

Backbone and sidechain 1H, 13C and 15N resonance assignments of the Bright/ARID domain from the human JARID1C (SMCX) protein Koehler, Christian; Bishop, Shurene; Dowler, Elizabeth F. Biomolecular NMR Assignments, Vol. 2, Issue 1 https://doi.org/10.1007/s12104-007-9071-7	journal	December 2007
A DNA Hypomethylation Signature Predicts Antitumor Activity of LSD1 Inhibitors in SCLC Mohammad, Helai P.; Smitheman, Kimberly N.; Kamat, Chandrashekhar D. Cancer Cell, Vol. 28, Issue 1 https://doi.org/10.1016/j.ccell.2015.06.002	journal	July 2015
The H3K4-Methyl Epigenome Regulates Leukemia Stem Cell Oncogenic Potential Wong, Stephen H. K.; Goode, David L.; Iwasaki, Masayuki Cancer Cell, Vol. 28, Issue 2 https://doi.org/10.1016/j.ccell.2015.06.003	journal	August 2015
Selective Killing of Mixed Lineage Leukemia Cells by a Potent Small-Molecule DOT1L Inhibitor Daigle, Scott R.; Olhava, Edward J.; Therkelsen, Carly A. Cancer Cell, Vol. 20, Issue 1 https://doi.org/10.1016/j.ccr.2011.06.009	journal	July 2011
Overcoming Intrinsic Multidrug Resistance in Melanoma by Blocking the Mitochondrial Respiratory Chain of Slow-Cycling JARID1Bhigh Cells Roesch, Alexander; Vultur, Adina; Bogeski, Ivan Cancer Cell, Vol. 23, Issue 6 https://doi.org/10.1016/j.ccr.2013.05.003	journal	June 2013
JARID1B Is a Luminal Lineage-Driving Oncogene in Breast Cancer Yamamoto, Shoji; Wu, Zhenhua; Russnes, Hege G. Cancer Cell, Vol. 25, Issue 6 https://doi.org/10.1016/j.ccr.2014.04.024	journal	June 2014
Histone Demethylation Mediated by the Nuclear Amine Oxidase Homolog LSD1 Shi, Yujiang; Lan, Fei; Matson, Caitlin Cell, Vol. 119, Issue 7 https://doi.org/10.1016/j.cell.2004.12.012	journal	December 2004
The Epigenomics of Cancer Jones, Peter A.; Baylin, Stephen B. Cell, Vol. 128, Issue 4 https://doi.org/10.1016/j.cell.2007.01.029	journal	February 2007
The Retinoblastoma Binding Protein RBP2 Is an H3K4 Demethylase Klose, Robert J.; Yan, Qin; Tothova, Zuzana Cell, Vol. 128, Issue 5 https://doi.org/10.1016/j.cell.2007.02.013	journal	March 2007
The X-Linked Mental Retardation Gene SMCX/JARID1C Defines a Family of Histone H3 Lysine 4 Demethylases Iwase, Shigeki; Lan, Fei; Bayliss, Peter Cell, Vol. 128, Issue 6 https://doi.org/10.1016/j.cell.2007.02.017	journal	March 2007
A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations Sharma, Sreenath V.; Lee, Diana Y.; Li, Bihua Cell, Vol. 141, Issue 1 https://doi.org/10.1016/j.cell.2010.02.027	journal	April 2010
A Temporarily Distinct Subpopulation of Slow-Cycling Melanoma Cells Is Required for Continuous Tumor Growth Roesch, Alexander; Fukunaga-Kalabis, Mizuho; Schmidt, Elizabeth C. Cell, Vol. 141, Issue 4 https://doi.org/10.1016/j.cell.2010.04.020	journal	May 2010
Cancer Epigenetics: From Mechanism to Therapy Dawson, Mark A.; Kouzarides, Tony Cell, Vol. 150, Issue 1 https://doi.org/10.1016/j.cell.2012.06.013	journal	July 2012
Balancing of Histone H3K4 Methylation States by the Kdm5c/SMCX Histone Demethylase Modulates Promoter and Enhancer Function Outchkourov, Nikolay S.; Muiño, Jose M.; Kaufmann, Kerstin Cell Reports, Vol. 3, Issue 4 https://doi.org/10.1016/j.celrep.2013.02.030	journal	April 2013
Histone Demethylase RBP2 Is Critical for Breast Cancer Progression and Metastasis Cao, Jian; Liu, Zongzhi; Cheung, William K. C. Cell Reports, Vol. 6, Issue 5 https://doi.org/10.1016/j.celrep.2014.02.004	journal	March 2014
Structural definitions of Jumonji family demethylase selectivity Pilka, Ewa S.; James, Tim; Lisztwan, Joanna Hergovich Drug Discovery Today, Vol. 20, Issue 6 https://doi.org/10.1016/j.drudis.2014.12.013	journal	June 2015
Exploring drug delivery for the DOT1L inhibitor pinometostat (EPZ-5676): Subcutaneous administration as an alternative to continuous IV infusion, in the pursuit of an epigenetic target Waters, Nigel J.; Daigle, Scott R.; Rehlaender, Bruce N. Journal of Controlled Release, Vol. 220 https://doi.org/10.1016/j.jconrel.2015.09.023	journal	December 2015
An Analog of BIX-01294 Selectively Inhibits a Family of Histone H3 Lysine 9 Jumonji Demethylases Upadhyay, Anup K.; Rotili, Dante; Han, Ji Woong Journal of Molecular Biology, Vol. 416, Issue 3 https://doi.org/10.1016/j.jmb.2011.12.036	journal	February 2012
Binding of pRB to the PHD Protein RBP2 Promotes Cellular Differentiation Benevolenskaya, Elizaveta V.; Murray, Heather L.; Branton, Philip Molecular Cell, Vol. 18, Issue 6 https://doi.org/10.1016/j.molcel.2005.05.012	journal	June 2005
PLU-1 Is an H3K4 Demethylase Involved in Transcriptional Repression and Breast Cancer Cell Proliferation Yamane, Kenichi; Tateishi, Keisuke; Klose, Robert J. Molecular Cell, Vol. 25, Issue 6 https://doi.org/10.1016/j.molcel.2007.03.001	journal	March 2007
Assessing and maximizing data quality in macromolecular crystallography Karplus, P. Andrew; Diederichs, Kay Current Opinion in Structural Biology, Vol. 34 https://doi.org/10.1016/j.sbi.2015.07.003	journal	October 2015
EPZ011989, A Potent, Orally-Available EZH2 Inhibitor with Robust in Vivo Activity Campbell, John E.; Kuntz, Kevin W.; Knutson, Sarah K. ACS Medicinal Chemistry Letters, Vol. 6, Issue 5 https://doi.org/10.1021/acsmedchemlett.5b00037	journal	March 2015
Cloning of cDNAs for cellular proteins that bind to the retinoblastoma gene product Defeo-Jones, Deborah; Huang, Pearl S.; Jones, Raymond E. Nature, Vol. 352, Issue 6332 https://doi.org/10.1038/352251a0	journal	July 1991
Crystal structures of histone demethylase JMJD2A reveal basis for substrate specificity Ng, Stanley S.; Kavanagh, Kathryn L.; McDonough, Michael A. Nature, Vol. 448, Issue 7149 https://doi.org/10.1038/nature05971	journal	June 2007
Recognition of unmethylated histone H3 lysine 4 links BHC80 to LSD1-mediated gene repression Lan, Fei; Collins, Robert E.; De Cegli, Rossella Nature, Vol. 448, Issue 7154 https://doi.org/10.1038/nature06034	journal	August 2007
Haematopoietic malignancies caused by dysregulation of a chromatin-binding PHD finger Wang, Gang G.; Song, Jikui; Wang, Zhanxin Nature, Vol. 459, Issue 7248 https://doi.org/10.1038/nature08036	journal	June 2009
Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes Dalgliesh, Gillian L.; Furge, Kyle; Greenman, Chris Nature, Vol. 463, Issue 7279 https://doi.org/10.1038/nature08672	journal	January 2010
A selective jumonji H3K27 demethylase inhibitor modulates the proinflammatory macrophage response Kruidenier, Laurens; Chung, Chun-wa; Cheng, Zhongjun Nature, Vol. 488, Issue 7411 https://doi.org/10.1038/nature11262	journal	July 2012
EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations McCabe, Michael T.; Ott, Heidi M.; Ganji, Gopinath Nature, Vol. 492, Issue 7427 https://doi.org/10.1038/nature11606	journal	October 2012
Structure of a Naegleria Tet-like dioxygenase in complex with 5-methylcytosine DNA Hashimoto, Hideharu; Pais, June E.; Zhang, Xing Nature, Vol. 506, Issue 7488 https://doi.org/10.1038/nature12905	journal	December 2013
Inhibition of demethylases by GSK-J1/J4 Heinemann, Bo; Nielsen, Jesper Morten; Hudlebusch, Heidi Rye Nature, Vol. 514, Issue 7520 https://doi.org/10.1038/nature13688	journal	October 2014
Dimethyl sulfoxide to vorinostat: development of this histone deacetylase inhibitor as an anticancer drug Marks, Paul A.; Breslow, Ronald Nature Biotechnology, Vol. 25, Issue 1 https://doi.org/10.1038/nbt1272	journal	January 2007
Prolonged and tunable residence time using reversible covalent kinase inhibitors Bradshaw, J. Michael; McFarland, Jesse M.; Paavilainen, Ville O. Nature Chemical Biology, Vol. 11, Issue 7 https://doi.org/10.1038/nchembio.1817	journal	May 2015
Chemical phylogenetics of histone deacetylases Bradner, James E.; West, Nathan; Grachan, Melissa L. Nature Chemical Biology, Vol. 6, Issue 3 https://doi.org/10.1038/nchembio.313	journal	February 2010
A small molecule modulates Jumonji histone demethylase activity and selectively inhibits cancer growth Wang, Lei; Chang, Jianjun; Varghese, Diana Nature Communications, Vol. 4, Issue 1 https://doi.org/10.1038/ncomms3035	journal	June 2013
Histone demethylase KDM5A is regulated by its reader domain through a positive-feedback mechanism Torres, Idelisse Ortiz; Kuchenbecker, Kristopher M.; Nnadi, Chimno I. Nature Communications, Vol. 6, Issue 1 https://doi.org/10.1038/ncomms7204	journal	February 2015
Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome Heintzman, Nathaniel D.; Stuart, Rhona K.; Hon, Gary Nature Genetics, Vol. 39, Issue 3 https://doi.org/10.1038/ng1966	journal	February 2007
The Phyre2 web portal for protein modeling, prediction and analysis Kelley, Lawrence A.; Mezulis, Stefans; Yates, Christopher M. Nature Protocols, Vol. 10, Issue 6 https://doi.org/10.1038/nprot.2015.053	journal	May 2015
Epigenetic therapy of cancer: past, present and future Yoo, Christine B.; Jones, Peter A. Nature Reviews Drug Discovery, Vol. 5, Issue 1 https://doi.org/10.1038/nrd1930	journal	January 2006
Epigenetic protein families: a new frontier for drug discovery Arrowsmith, Cheryl H.; Bountra, Chas; Fish, Paul V. Nature Reviews Drug Discovery, Vol. 11, Issue 5 https://doi.org/10.1038/nrd3674	journal	April 2012
The ankyrin repeats of G9a and GLP histone methyltransferases are mono- and dimethyllysine binding modules Collins, Robert E.; Northrop, Jeffrey P.; Horton, John R. Nature Structural & Molecular Biology, Vol. 15, Issue 3 https://doi.org/10.1038/nsmb.1384	journal	February 2008
The ARID domain of the H3K4 demethylase RBP2 binds to a DNA CCGCCC motif Tu, Shengjiang; Teng, Yu-Ching; Yuan, Chunhua Nature Structural & Molecular Biology, Vol. 15, Issue 4 https://doi.org/10.1038/nsmb.1400	journal	February 2008
Enzymatic and structural insights for substrate specificity of a family of jumonji histone lysine demethylases Horton, John R.; Upadhyay, Anup K.; Qi, Hank H. Nature Structural & Molecular Biology, Vol. 17, Issue 1 https://doi.org/10.1038/nsmb.1753	journal	December 2009
The von Hippel–Lindau tumor suppressor protein regulates gene expression and tumor growth through histone demethylase JARID1C Niu, X.; Zhang, T.; Liao, L. Oncogene, Vol. 31, Issue 6 https://doi.org/10.1038/onc.2011.266	journal	July 2011
Systematic knockdown of epigenetic enzymes identifies a novel histone demethylase PHF8 overexpressed in prostate cancer with an impact on cell proliferation, migration and invasion Björkman, M.; Östling, P.; Härmä, V. Oncogene, Vol. 31, Issue 29 https://doi.org/10.1038/onc.2011.512	journal	November 2011
PARP1 exhibits enhanced association and catalytic efficiency with γH2A.X-nucleosome Sharma, Deepti; De Falco, Louis; Padavattan, Sivaraman Nature Communications, Vol. 10, Issue 1 https://doi.org/10.1038/s41467-019-13641-0	journal	December 2019
Cavin1 intrinsically disordered domains are essential for fuzzy electrostatic interactions and caveola formation Tillu, Vikas A.; Rae, James; Gao, Ya Nature Communications, Vol. 12, Issue 1 https://doi.org/10.1038/s41467-021-21035-4	journal	February 2021
JmjC Lysine Demethylases Cheng, Xiaodong; Trievel, Raymond C. 2-Oxoglutarate-Dependent Oxygenases https://doi.org/10.1039/9781782621959-00210	book	May 2015
Targeting Epigenetic Readers in Cancer Dawson, Mark A.; Kouzarides, Tony; Huntly, Brian J. P. New England Journal of Medicine, Vol. 367, Issue 7 https://doi.org/10.1056/NEJMra1112635	journal	August 2012
JARID1B is a histone H3 lysine 4 demethylase up-regulated in prostate cancer Xiang, Y.; Zhu, Z.; Han, G. Proceedings of the National Academy of Sciences, Vol. 104, Issue 49 https://doi.org/10.1073/pnas.0700735104	journal	November 2007
Loss of the retinoblastoma binding protein 2 (RBP2) histone demethylase suppresses tumorigenesis in mice lacking Rb1 or Men1 Lin, W.; Cao, J.; Liu, J. Proceedings of the National Academy of Sciences, Vol. 108, Issue 33 https://doi.org/10.1073/pnas.1110104108	journal	July 2011
Targeting H3K4 trimethylation in Huntington disease Vashishtha, M.; Ng, C. W.; Yildirim, F. Proceedings of the National Academy of Sciences, Vol. 110, Issue 32 https://doi.org/10.1073/pnas.1311323110	journal	July 2013
A Novel Gene ( PLU-1 ) Containing Highly Conserved Putative DNA/Chromatin Binding Motifs Is Specifically Up-regulated in Breast Cancer Lu, Pei Juan; Sundquist, Kristina; Baeckstrom, Dan Journal of Biological Chemistry, Vol. 274, Issue 22 https://doi.org/10.1074/jbc.274.22.15633	journal	May 1999
Catalytic Mechanisms of Fe(II)- and 2-Oxoglutarate-dependent Oxygenases Martinez, Salette; Hausinger, Robert P. Journal of Biological Chemistry, Vol. 290, Issue 34 https://doi.org/10.1074/jbc.R115.648691	journal	July 2015
Kinetic studies of Escherichia coli AlkB using a new fluorescence-based assay for DNA demethylation Roy, Todd W.; Bhagwat, A. S. Nucleic Acids Research, Vol. 35, Issue 21 https://doi.org/10.1093/nar/gkm1031	journal	November 2007
Structural basis for histone H3 Lys 27 demethylation by UTX/KDM6A Sengoku, T.; Yokoyama, S. Genes & Development, Vol. 25, Issue 21 https://doi.org/10.1101/gad.172296.111	journal	October 2011
The landscape of histone modifications across 1% of the human genome in five human cell lines Koch, C. M.; Andrews, R. M.; Flicek, P. Genome Research, Vol. 17, Issue 6 https://doi.org/10.1101/gr.5704207	journal	June 2007
Multiparametric scaling of diffraction intensities Otwinowski, Zbyszek; Borek, Dominika; Majewski, Wladyslaw Acta Crystallographica Section A Foundations of Crystallography, Vol. 59, Issue 3 https://doi.org/10.1107/S0108767303005488	journal	April 2003
PHENIX : building new software for automated crystallographic structure determination Adams, Paul D.; Grosse-Kunstleve, Ralf W.; Hung, Li-Wei Acta Crystallographica Section D Biological Crystallography, Vol. 58, Issue 11 https://doi.org/10.1107/S0907444902016657	journal	October 2002
Coot model-building tools for molecular graphics Emsley, Paul; Cowtan, Kevin Acta Crystallographica Section D Biological Crystallography, Vol. 60, Issue 12, p. 2126-2132 https://doi.org/10.1107/S0907444904019158	journal	November 2004
PHENIX: a comprehensive Python-based system for macromolecular structure solution Adams, Paul D.; Afonine, Pavel V.; Bunkóczi, Gábor Acta Crystallographica Section D Biological Crystallography, Vol. 66, Issue 2, p. 213-221 https://doi.org/10.1107/S0907444909052925	journal	January 2010
Features and development of Coot Emsley, P.; Lohkamp, B.; Scott, W. G. Acta Crystallographica Section D Biological Crystallography, Vol. 66, Issue 4 https://doi.org/10.1107/S0907444910007493	journal	March 2010
Studies of H3K4me3 demethylation by KDM5B/Jarid1B/PLU1 reveals strong substrate recognition in vitro and identifies 2,4-pyridine-dicarboxylic acid as an in vitro and in cell inhibitor: In vitro studies of histone demethylase KDM5B Kristensen, Line H.; Nielsen, Anders L.; Helgstrand, Charlotte FEBS Journal, Vol. 279, Issue 11 https://doi.org/10.1111/j.1742-4658.2012.08567.x	journal	May 2012
Linking Crystallographic Model and Data Quality Karplus, P. A.; Diederichs, K. Science, Vol. 336, Issue 6084 https://doi.org/10.1126/science.1218231	journal	May 2012
Genetic Events That Shape the Cancer Epigenome Ryan, R. J. H.; Bernstein, B. E. Science, Vol. 336, Issue 6088 https://doi.org/10.1126/science.1223730	journal	June 2012
Functional Analysis of the Transcription Repressor PLU-1/JARID1B Scibetta, A. G.; Santangelo, S.; Coleman, J. Molecular and Cellular Biology, Vol. 27, Issue 20 https://doi.org/10.1128/MCB.00274-07	journal	August 2007
Delivery of 5-Aza-2'-Deoxycytidine to Cells Using Oligodeoxynucleotides Yoo, C. B.; Jeong, S.; Egger, G. Cancer Research, Vol. 67, Issue 13 https://doi.org/10.1158/0008-5472.CAN-07-0251	journal	July 2007
Selective Inhibition of EZH2 by EPZ-6438 Leads to Potent Antitumor Activity in EZH2-Mutant Non-Hodgkin Lymphoma Knutson, S. K.; Kawano, S.; Minoshima, Y. Molecular Cancer Therapeutics, Vol. 13, Issue 4 https://doi.org/10.1158/1535-7163.MCT-13-0773	journal	February 2014
Lysine Demethylase KDM4A Associates with Translation Machinery and Regulates Protein Synthesis Van Rechem, C.; Black, J. C.; Boukhali, M. Cancer Discovery, Vol. 5, Issue 3 https://doi.org/10.1158/2159-8290.CD-14-1326	journal	January 2015
Potent inhibition of DOT1L as treatment of MLL-fusion leukemia Daigle, Scott R.; Olhava, Edward J.; Therkelsen, Carly A. Blood, Vol. 122, Issue 6 https://doi.org/10.1182/blood-2013-04-497644	journal	August 2013
KDM5B focuses H3K4 methylation near promoters and enhancers during embryonic stem cell self-renewal and differentiation Kidder, Benjamin L.; Hu, Gangqing; Zhao, Keji Genome Biology, Vol. 15, Issue 2 https://doi.org/10.1186/gb-2014-15-2-r32	journal	January 2014
Structural Basis of a Histone H3 Lysine 4 Demethylase Required for Stem Elongation in Rice Chen, Qingfeng; Chen, Xiangsong; Wang, Quan PLoS Genetics, Vol. 9, Issue 1 https://doi.org/10.1371/journal.pgen.1003239	journal	January 2013
Romidepsin: a novel histone deacetylase inhibitor for cancer Bertino, Erin M.; Otterson, Gregory A. Expert Opinion on Investigational Drugs, Vol. 20, Issue 8 https://doi.org/10.1517/13543784.2011.594437	journal	June 2011
PHENIX: a comprehensive Python-based system for macromolecular structure solution. Adams, Paul D.; Afonine, Pavel V.; Bunkóczi, Gábor Apollo - University of Cambridge Repository https://doi.org/10.17863/cam.45787	text	January 2010
The KDM5 family of histone demethylases as targets in oncology drug discovery Rasmussen, Peter Birk; Staller, Peter Epigenomics, Vol. 6, Issue 3 https://doi.org/10.2217/epi.14.14	journal	June 2014
KDM1 histone lysine demethylases as targets for treatments of oncological and neurodegenerative disease Maes, Tamara; Mascaró, Cristina; Ortega, Alberto Epigenomics, Vol. 7, Issue 4 https://doi.org/10.2217/epi.15.9	journal	June 2015

Cited By (16)

KDM5 demethylases and their role in cancer cell chemoresistance: KDM5 demethylases Plch, Johana; Hrabeta, Jan; Eckschlager, Tomas International Journal of Cancer, Vol. 144, Issue 2 https://doi.org/10.1002/ijc.31881	journal	November 2018
Epigenetics of Breast Cancer: Clinical Status of Epi-drugs and Phytochemicals Shukla, Samriddhi; Penta, Dhanamjai; Mondal, Priya Breast Cancer Metastasis and Drug Resistance: Challenges and Progress, p. 293-310 https://doi.org/10.1007/978-3-030-20301-6_16	book	August 2019
Lysine-specific demethylase 1 cooperates with BRAF–histone deacetylase complex 80 to enhance HIV-1 Tat-mediated transactivation Liu, Yu; Zhou, Deyu; Qi, Di Virus Genes, Vol. 54, Issue 5 https://doi.org/10.1007/s11262-018-1589-5	journal	August 2018
Extended Recognition of the Histone H3 Tail by Histone Demethylase KDM5A Petronikolou, Nektaria; Longbotham, James E.; Fujimori, Danica Galonić Biochemistry, Vol. 59, Issue 5 https://doi.org/10.1021/acs.biochem.9b01036	journal	January 2020
Structural analysis of human KDM5B guides histone demethylase inhibitor development Johansson, Catrine; Velupillai, Srikannathasan; Tumber, Anthony Nature Chemical Biology, Vol. 12, Issue 7 https://doi.org/10.1038/nchembio.2087	journal	May 2016
Histone H3 binding to the PHD1 domain of histone demethylase KDM5A enables active site remodeling Longbotham, James E.; Chio, Cynthia M.; Dharmarajan, Venkatasubramanian Nature Communications, Vol. 10, Issue 1 https://doi.org/10.1038/s41467-018-07829-z	journal	January 2019
The transition structure of chromatin fibers at the nanoscale probed by cryogenic electron tomography Zhou, Zhongwu; Li, Kunpeng; Yan, Rui Nanoscale, Vol. 11, Issue 29 https://doi.org/10.1039/c9nr02042j	journal	January 2019
JARID1/KDM5 demethylases as cancer targets? Taylor-Papadimitriou, Joyce; Burchell, Joy Expert Opinion on Therapeutic Targets, Vol. 21, Issue 1 https://doi.org/10.1080/14728222.2017.1263616	journal	November 2016
A CRISPR/Cas9 screen identifies the histone demethylase MINA53 as a novel HIV-1 latency-promoting gene (LPG) Huang, Huachao; Kong, Weili; Jean, Maxime Nucleic Acids Research, Vol. 47, Issue 14 https://doi.org/10.1093/nar/gkz493	journal	June 2019
Histone Lysine Demethylase Inhibitors Jambhekar, Ashwini; Anastas, Jamie N.; Shi, Yang Cold Spring Harbor Perspectives in Medicine, Vol. 7, Issue 1 https://doi.org/10.1101/cshperspect.a026484	journal	October 2016
The H3K4 demethylase Jar1 orchestrates ROS production and expression of pathogenesis‐related genes to facilitate Botrytis cinerea virulence Hou, Jie; Feng, Hui‐Qiang; Chang, Hao‐Wu New Phytologist, Vol. 225, Issue 2 https://doi.org/10.1111/nph.16200	journal	October 2019
Xue-fu-Zhu-Yu decoction protects rats against retinal ischemia by downregulation of HIF-1α and VEGF via inhibition of RBP2 and PKM2 Tan, Shu-Qiu; Geng, Xue; Liu, Jorn-Hon BMC Complementary and Alternative Medicine, Vol. 17, Issue 1 https://doi.org/10.1186/s12906-017-1857-2	journal	July 2017
Assessing histone demethylase inhibitors in cells: lessons learned Hatch, Stephanie B.; Yapp, Clarence; Montenegro, Raquel C. Epigenetics & Chromatin, Vol. 10, Issue 1 https://doi.org/10.1186/s13072-017-0116-6	journal	March 2017
Histone demethylase JARID1B/KDM5B promotes aggressiveness of non-small cell lung cancer and serves as a good prognostic predictor Kuo, Kuang-Tai; Huang, Wen-Chien; Bamodu, Oluwaseun Adebayo Clinical Epigenetics, Vol. 10, Issue 1 https://doi.org/10.1186/s13148-018-0533-9	journal	August 2018
Genetic heterogeneity within collective invasion packs drives leader and follower cell phenotypes Zoeller, Elizabeth L.; Pedro, Brian; Konen, Jessica Journal of Cell Science, Vol. 132, Issue 19 https://doi.org/10.1242/jcs.231514	journal	September 2019
KDM5 histone demethylases repress immune response via suppression of STING Wu, Lizhen; Cao, Jian; Cai, Wesley L. PLOS Biology, Vol. 16, Issue 8 https://doi.org/10.1371/journal.pbio.2006134	journal	August 2018

Similar Records

Structural Basis for KDM5A Histone Lysine Demethylase Inhibition by Diverse Compounds

Journal Article · Wed Jul 13 20:00:00 EDT 2016 · Cell Chemical Biology · OSTI ID:1324770

Structure-Based Engineering of Irreversible Inhibitors against Histone Lysine Demethylase KDM5A

Journal Article · Fri Nov 02 20:00:00 EDT 2018 · Journal of Medicinal Chemistry · OSTI ID:1506493

An Analog of BIX-01294 Selectively Inhibits a Family of Histone H3 Lysine 9 Jumonji Demethylases

Journal Article · Mon Mar 26 00:00:00 EDT 2012 · Journal of Molecular Biology · OSTI ID:1036324

Related Subjects

37 INORGANIC, ORGANIC, PHYSICAL, AND ANALYTICAL CHEMISTRY
59 BASIC BIOLOGICAL SCIENCES
dioxygenase
histone demethylase
histone modification
metal ion-protein interaction
molecular modeling

Characterization of a Linked Jumonji Domain of the KDM5/JARID1 Family of Histone H3 Lysine 4 Demethylases

Citation Formats

References (76)

Cited By (16)

Similar Records

Related Subjects